RVTY|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $1.22 | - | - |
| Q1'26 | $1.23 | $1.06 | -13.8% |
| Q4'25 | $1.58 | $1.70 | +7.5% |
| Q3'25 | $1.14 | $1.18 | +3.6% |
| Q2'25 | $1.14 | $1.18 | +3.4% |
| Q1'25 | $0.95 | $1.01 | +6.4% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $725M | - | - |
| Q1'26 | $736M | $711M | -3.4% |
| Q4'25 | $777M | $772M | -0.6% |
| Q3'25 | - | $699M | - |
| Q2'25 | - | $720M | - |
| Q1'25 | - | $665M | - |
Market Data
RVTY Stock Snapshot
RVTY is currently trading at $96.33, giving Revvity, Inc. a market cap of 10.82B and a P/E ratio of 45.1. Today's range spans $95.61–$97.07, with shares opening at $97.05 and moving down $0.62 (0.6%) from the prior close. DailyIQ's technical score sits at 64/100 (HOLD) with a news sentiment reading of 66/100.
Over the past year RVTY has traded between $81.22 and $118.30 - the current price is +18.6% off the 52-week low and -18.6% from the high.
RVTY trades at $96.33 (in the lower half of its 52-week range within $81.22–$118.30) - and the HOLD signal (64/100) reflects a market that's fairly priced relative to near-term expectations rather than one that's mispriced in either direction. (P/E: 45.1) At 10.82B in Healthcare market cap, bullish sentiment (66/100) confirms the lack of near-term narrative catalyst. The thesis is intact; the timing is patient.
The 52-week range of $81.22–$118.30 for RVTY provides the structural reference that options traders, systematic funds, and discretionary managers all anchor to — and at $96.33 (in the lower half of its 52-week range), the stock sits in a zone where the next 5–10% move will likely define which crowd was right. A HOLD signal at 64/100 and bullish news backdrop (66/100) don't break the tie yet, but they narrow the probability distribution toward the upside.
Recent News Coverage
Most recent articles, ranked by recency (click to expand).